Novel Therapies, Clinical Lab Impact Novel therapies discussed at the ELRIG Drug Discovery USA 2026 conference could eventually create new opportunities—and new challenges—for clinical laboratories as more targeted treatments move toward routine clinical use. Speakers highlighted emerging approaches such as molecular glues, targeted protein degradation, and other precision therapies designed to act on disease-causing proteins […]
July, 2026, Intelligence
- By Janette Wider
- > From the Volume XXXIII, No. 9 - July, 2026 Issue
